Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Renner P et al. – Mesenchymal stem cells (MSC) have emerged to be one of the most promising candidates for cellular immunotherapy in solid organ transplantation because the reduction of conventional immunosuppression is highly desirable. However, little is known about the details of MSC–mediated immunomodulation and their clinical relevance.


Today in Vaccine/Immunotherapy...keeping you current

Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09

Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09

Yearly influenza vaccinations: a double-edged sword
The Lancet Infectious Diseases, 11/19/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address